PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include the best treatment for ear infections in kids with tubes, first-line treatment for atrial fibrillation, how to manage asymptomatic AVMs, and citalopram for agitation in Alzheimer's disease. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - February 21, 2014 Category: Psychiatry Source Type: news

Anti-depressant Citalopram could help ease Alzheimer's symptoms
The drug Citalopram - sold under the brand names Celexa and Cipramil - significantly relieved agitation in a group of Alzheimer's patients. (Source: the Mail online | Health)
Source: the Mail online | Health - February 19, 2014 Category: Consumer Health News Source Type: news

Antidepressant Celexa May Help Ease Alzheimer's-Linked Agitation
Title: Antidepressant Celexa May Help Ease Alzheimer's-Linked AgitationCategory: Health NewsCreated: 2/18/2014 4:36:00 PMLast Editorial Review: 2/19/2014 12:00:00 AM (Source: MedicineNet Alzheimer)
Source: MedicineNet Alzheimer - February 19, 2014 Category: Geriatrics Source Type: news

Citalopram Associated with Reduced Agitation in Alzheimer's, But at What Cost? (FREE)
By Kelly Young The selective serotonin reuptake inhibitor citalopram is associated with reduced agitation in people with Alzheimer disease — but with significant side effects — according to a JAMA study.Nearly 200 patients with probable Alzheimer's … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 19, 2014 Category: Primary Care Source Type: news

Citalopram Reduces Agitation in Patients With Alzheimer's Citalopram Reduces Agitation in Patients With Alzheimer's
Results of the CitAD trial show 30 mg daily moderates agitation in AD but also affects cognition, can cause electrocardiography changes, and is no longer recommended in older adults. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 18, 2014 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Antidepressant Celexa May Help Ease Alzheimer's Linked Agitation
Study finds it might be safer alternative to standard antipsychotics Source: HealthDay Related MedlinePlus Pages: Alzheimer's Disease, Antidepressants (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 18, 2014 Category: Consumer Health News Source Type: news

Celexa Eases Alzheimer's Agitation, But Safety Unclear (CME/CE)
(MedPage Today) -- A well-known antidepressant reduced agitation in people with probable Alzheimer's disease, but with some adverse cardiac and cognitive effects, researchers reported. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - February 18, 2014 Category: Psychiatry Source Type: news

Citalopram Side Effects (Brand Name Celexa)
List of Citalopram side effects. Citalopram (brand name Celexa) is an antidepressant sometimes prescribed in the treatment of bipolar disorder and other mood disorders. You need to know about potential side effects if you are taking or considering taking this medication. (Source: About.com Bipolar Disorder)
Source: About.com Bipolar Disorder - August 2, 2013 Category: Psychiatry Authors: bipolar.guide at about.com Tags: health Source Type: news

Celexa (Citalopram) - Medication Profile
Celexa - generic citalopram - is a medication used to treat depression. Celexa is a member of the SSRI drug family. These drugs work by making more serotonin available between nerve cells, which has been shown to ease depression. Article covers the benefits of Celexa, precautions and warnings, and information regarding pregnancy and Celexa. (Source: About.com Bipolar Disorder)
Source: About.com Bipolar Disorder - July 30, 2013 Category: Psychiatry Authors: bipolar.guide at about.com Tags: health Source Type: news

Citalopram and the QT Interval RevisitedCitalopram and the QT Interval Revisited
Contrasting with FDA warnings, does this study suggest that they are wrong about citalopram? Medscape Psychiatry (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 19, 2013 Category: Consumer Health News Tags: Psychiatry Viewpoint Source Type: news

FDA Citalopram Warning 'Without Merit'FDA Citalopram Warning 'Without Merit'
A recent FDA warning about an increased risk for cardiovascular events and mortality with higher doses of the antidepressant citalopram is "without merit," new research suggests. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - June 5, 2013 Category: Psychiatry Tags: Psychiatry News Source Type: news

citalopram, Celexa
Title: citalopram, CelexaCategory: MedicationsCreated: 2/2/1999 10:38:00 PMLast Editorial Review: 5/31/2013 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - May 31, 2013 Category: Psychiatry Source Type: news

Warning By FDA Against High Dose Antidepressant Prescription May Be Unwarranted
The U.S. Food and Drug Administration's warning that high doses of the antidepressant citalopram can cause potentially serious abnormal heart rhythms might be doing more harm than good. In 2011, the FDA attached a warning to the drug, also known as Celexa, based on data linking higher doses of the drug to potentially fatal abnormal changes in the electrical activity of the heart... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 7, 2013 Category: Consumer Health News Tags: Depression Source Type: news

FDA warning against high dose antidepressant prescription may be unwarranted, study finds
(University of Michigan Health System) A new Ann Arbor VA Healthcare System and University of Michigan study calls into question the FDA's warning against high dosages of citalopram after finding no increased risk for abnormal heart rhythms or death in patients who took daily doses of more than 40 milligrams before or after the warning took effect. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 3, 2013 Category: Global & Universal Source Type: news

Contributory and incidental blood concentrations in deaths involving citalopram - Darke S, Torok M, Duflou J.
All cases presenting to the New South Wales Department of Forensic Medicine between January 1, 2001 and December 31, 2010 in which citalopram was detected were retrieved. A total of 348 cases were identified. Citalopram contributed to death in 21.0%, and w... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - February 26, 2013 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news